Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.

IGM Biosciences Inc. said Thursday it is cutting 73% of its workforce after deciding to halt further development of a program relating to its autoimmunity-drug pipeline, sending its stock down 69% in ...

Pfizer’s “golden egg” has hatched. The subcutaneous PD-1 inhibitor improved outcomes when added to the standard of care in ...

A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung ...

Chicago-based Meitheal Pharmaceuticals, along with its Chinese parent, was busy in 2024, adding both biosimilar drugs and ...

Women diagnosed with advanced breast cancer appeared more likely than those with earlier-stage breast cancer to have ...

A 72-year-old cancer patient in Bengaluru took his life after being denied coverage under the Ayushman Bharat PM-JAY scheme.

Research in cancer genetics continues to unravel complex genetic interactions and their implications for cancer development and treatment. Reviews in Cancer ...

In the span of eight months, Big Pharma companies took over four of the hottest radiopharmaceutical players in the industry.

Oral cancer is an increasingly prevalent disease worldwide, with over 300,000 new cases diagnosed each year. Among oral cancers, tongue cancer (TC) is the most common type and often carries a poor ...

A new study demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a ...

Each year, over 1.2 million Americans receive a cancer diagnosis, a journey that can be both overwhelming and daunting.